Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2026 Feb 13:S0091-6749(26)00083-7.
doi: 10.1016/j.jaci.2026.02.002. Online ahead of print.

Multicenter international cohort study of haploinsufficiency of A20 reveals novel genetic architecture and phenotypic evolution

Tingyan He  1 Jun Wang  2 Manuel Carpio Tumba  3 Shihao Wang  4 Youyou Luo  5 Jie Chen  5 Guomin Li  6 Zhou Shu  7 Song Zhang  8 Deborah L Stone  9 Yanyan Huang  10 Qianying Lv  6 Wen Xiong  10 Jinbo Wang  11 Zhongxun Yu  12 Charlotte Vera Cuff  3 Elizabeth Kairis  3 Akuti Kethri  3 Atif Towheed  3 Kyr Goyette  3 Urekha Karri  13 Jiebiao Wang  14 Chen Liu  14 Tina Romeo  9 Laia Alsina  15 Daniel L Rosenberg  16 Daniel Clemente  17 Juan Carlos López-Robledillo  17 Zanhua Rong  18 Xue Zhao  18 Lijun Jiang  18 Juan Carlos Aldave-Becerra  19 Ana Beatriz Muñoz-Urribarri  19 Prasad Thomas Oommen  20 Priscilla Campbell-Stokes  21 Meifang Zhu  22 Peng Liu  23 Li Guo  24 Yiping Xu  24 Zihua Yu  25 Huajuan Tong  25 Xiaojian Qiu  25 Yazhi Zhang  26 Hongbo Chen  26 Changming Zhang  27 Junbin Ou  28 Congcong Liu  29 Jinxiang Liu  29 Yunyan Shen  30 Jianshe Cao  31 Xinping Zhang  31 Kangkang Yang  32 Ying Bao  33 Zhijuan Li  33 Jie Cao  34 Yuanhui Duan  34 Fujuan Liu  35 Buyun Shi  36 Min Sun  37 Li Ma  37 Yongxing Chen  38 Wei Yang  38 Xu Han  2 Shuangyue Ma  2 Jie Luo  39 Weiyue Gu  40 Guoliang Yu  40 Weina Shi  41 Ruiqin Zhao  41 Lei Sun  42 Wenhui Li  43 Yunfei An  42 Xuemei Tang  42 Xiaodong Zhao  42 Tongxin Han  7 Jing Ma  7 Yan Li  7 Yurong Piao  7 Fei Sun  7 Dongfeng Zhang  35 Meina Yin  35 Shaoling Zheng  44 Tianwang Li  44 Huizhong Niu  45 Li Lin  46 Shiyue Mei  46 Fang Zhou  46 Sirui Yang  29 Danlu Li  47 Mei Yan  47 Huasong Zeng  8 Ping Zeng  8 Wenjie Zheng  32 Xiaozhong Li  30 Xiaolin Li  28 Yuling Liu  28 Lijuan Huang  28 Haiguo Yu  22 Zhidan Fan  22 Min Shen  48 Meiping Lu  24 Zhihao Fang  24 Casey Allison Rimland  49 Hongmei Song  12 Lance W Peterson  50 Maryam Ali Yousuf Al-Nesf  51 Sami Aqel  51 Dalal Sideeg Mudawi  51 Nikita Raje  52 Voytek Slowik  52 Julia G Harris  52 Brenda Snyder  52 Selma Scheffler-Mendoza  53 Marco Antonio Yamazaki-Nakashimada  53 Megan A Cooper  50 Yu Lung Lau  54 Kader Cetin Gedik  55 Wenjie Wang  56 Wenjing Ying  56 Jia Hou  56 Qinhua Zhou  56 Bijun Sun  56 Jinqiao Sun  56 Xiaochuan Wang  56 Amanda K Ombrello  9 Ying Huang  57 Hai-Lin Wu  57 Li Sun  6 Huawei Mao  7 Xiaomin Yu  2 Zhihong Liu  27 Ivona Aksentijevich  9 Daniel L Kastner  9 Daniella M Schwartz  58 Jun Yang  59 Qing Zhou  60
Affiliations

Multicenter international cohort study of haploinsufficiency of A20 reveals novel genetic architecture and phenotypic evolution

Tingyan He et al. J Allergy Clin Immunol. .

Abstract

Background: Haploinsufficiency of A20 (HA20) is an immune dysregulation disorder caused by loss-of-function TNFAIP3 mutations. This international multicenter study aimed to delineate its clinical spectrum, genetic basis, and natural history.

Methods: A cross-sectional retrospective analysis was conducted in HA20 patients with pathogenic or likely pathogenic TNFAIP3 variants. Clinical, laboratory, and treatment data were assessed. Clustering analysis was applied to evaluate clinical features and disease phenotypes. Patients were stratified by age (<16 years vs ≥16 years), country of origin (China vs United States), and sex.

Results: A total of 185 patients from 41 clinics across 7 countries were included (median age at onset, 3.3 years). Common clinical features were mucocutaneous involvement (80.5%), recurrent fever (63.3%), gastrointestinal symptoms (58.6%), cytopenia (56.6%), arthritis/arthralgia (46.7%), and recurrent infections (35.5%). Compared with adults and patients from the US cohort, intestinal ulcers were significantly more frequent in children and patients from the Chinese cohort (P = .002 and P < .0001, respectively), whereas uveitis was less common in these groups (P = .001 and P < .0001, respectively). Hierarchical clustering of clinical disease phenotypes based on Pearson distance identified two major clusters, an autoinflammation-predominant phenotype and an autoimmune-predominant phenotype. The autoinflammation-predominant phenotype was more common in children and patients from the Chinese cohort (P = .033 and .003, respectively). A total of 89 pathogenic TNFAIP3 mutations were identified, including 46 novel variants. Large deletions were associated with neurologic disease and developmental delay (P = .0054 and .0245, respectively); however, there were no clear associations between disruptions of specific functional A20 domains and age at onset or phenotype. Therapeutically, TNF and IL-1 inhibitors were effective in most patients, with thalidomide and JAK inhibitors provided in refractory cases; 51.5% had obtained minimal disease activity at most recent follow-up.

Conclusions: HA20 is a common dominantly inherited immune dysregulation disorder with phenotypic heterogeneity and potential age-dependent evolution. This large international cohort highlights diagnostic and therapeutic strategies to advance evaluation and management of HA20.

Keywords: Haploinsufficiency of A20; TNFAIP3; autoimmunity; autoinflammation.

PubMed Disclaimer

Conflict of interest statement

Disclosure statement T.H. received grant SZTP05202501005 from Special Support Program for High-level Talents in Shenzhen Health System and grant 82302056 from the National Natural Science Foundation of China. Q.Z. received grants 82225022, 32141004 and 32321002 from the National Natural Science Foundation of China, the XPLORER PRIZE from the New Cornerstone Science Foundation, grant 2024YFC2511002 from the National Key Research and Development Program of China, and grant CHCMU-2024-XKDF-1001 from Clinical Research Project for the Summit Program of Children’s Hospital of Chongqing Medical University. J.Y. received grant SZSM202411012 supported by Sanming Project of Medicine in Shenzhen. D.M.S. received grants by Jeffrey Modell Foundation, Eli Lilly, Sobi, and the Samuel and Emma Winters Foundation, and Rheumatology Research Foundation. J.W received grants 82394420, 82394423, and 82402121 from the National Natural Science Foundation of China and grant 2023M733104 from China Postdoctoral Science Foundation. S.W. received grant 82402118 from the National Natural Science Foundation of China. L.G. received the grant LHDMY23H100005 from Joint Funds of the Zhejiang Provincial Natural Science Foundation of China. X.Y. received grants 82394420, 82394424, and 82471844 from the National Natural Science Foundation of China, the Hundred-Talent Program of Zhejiang University, grant 2021R01012 from the Leading Innovative and Entrepreneur Team Introduction Program of Zhejiang and grant 2024Z221 from the Key Technology Breakthrough Program of Ningbo Sci-Tech Innovation YONGJIANG 2035. Y.L.L. received a grant from the Hong Kong Society for Relief of Disabled Children. This research was supported in part by the Intramural Research Program of the National Institutes of Health (NIH). The contributions of the NIH authors are considered Works of the United States Government. The findings and conclusions presented in this paper are those of the authors and do not necessarily reflect the views of the NIH or the US Department of Health and Human Services. Disclosure of potential conflict of interest: W. Gu and G. Yu are employees of Chigene (Beijing) Translational Medical Research Center Co Ltd and Beijing Quanpu Medical Laboratory Co Ltd. D. M. Schwartz has received consulting fees from Sobi and grant support from Sobi and Eli Lilly. The rest of the authors declare that they have no relevant conflicts of interest.

LinkOut - more resources